ON TARGET LABORATORIES
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $15.0m | Late VC | |
$1.7m | Early VC | ||
$40.0m | Series B | ||
$4.0m | Series B | ||
$21.0m | Series B | ||
$3.0m | Convertible | ||
* | $30.0m Valuation: $200m | Series C | |
Total Funding | $115m |
Recent News about ON TARGET LABORATORIES
EditOn Target Laboratories specializes in the discovery and development of fluorescent markers that target and illuminate cancerous tissues during surgical procedures. This technology provides surgeons with enhanced intraoperative visibility, potentially increasing the likelihood of complete cancer resection. The primary clients are healthcare providers, particularly surgeons and hospitals, operating in the oncology sector. On Target Laboratories operates within the medical technology market, focusing on innovative solutions to improve surgical outcomes. The business model revolves around the research, development, and commercialization of its fluorescent imaging technology. Revenue is generated through the sale of these specialized markers and potentially through partnerships or licensing agreements with medical institutions and technology firms.
Keywords: fluorescent markers, cancer visibility, surgical resection, oncology, intraoperative imaging, healthcare providers, medical technology, surgical outcomes, commercialization, innovation.